Drug Target Review – Issue #3 2016

Posted: 20 September 2016 | Drug Target Review | No comments yet

In Issue #3 2016: Flow Cytometry, Enzymes, Imaging, GPCRs, Hit-To-Lead, CNS, Companion Diagnostics, and much more…

DTR Issue 3 iPad

In Issue #3 2016 of Drug Target Review:

  • FOREWORD: Paying to be obvious – ingenuity and patent law
    Jacob Gifford Head, Thomas More Chambers
  • FLOW CYTOMETRY: Breaking bottlenecks in drug discovery and development
    Pushpanathan Muthuirulan, National Institutes of Health and Pooja Sharma, University of Maryland
  • ENZYMES: Switching on genes regulating oxysterol synthesis – a therapeutic option?
    Steve Meaney, Dublin Institute of Technology
    With articles from Norman Peterson, MedImmune/AstraZeneca, and Janet Brownlees, Emilie Bureau, Jenny Cook and Debra Taylor, MRC Technology
  • GPCRs: High-throughput calcium flux assays – luminescent versus fluorescent readout
    Nicolas Houvenaghel, Jans Mia, Van der Schueren Jan and Christophe Thierry, Galapagos NV
    With contributions from Douglas B. Kitchen and Mark Wolf, Albany Molecular Research, and Martina Fenske and Sheraz Gul, Fraunhofer IME
  • CNS: Fibromyalgia pathogenesis provides drug target clues
    Kim Lawson, Sheffield Hallam University
    Interview with Pierre Belichard, CEO of Enterome Biosciences

Issue #3 2016 is restricted to logged-in members. Login or subscribe free to read it.

Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend